Comparison of the effects of three oral bisphosphonate therapies on the peripheral skeleton in postmenopausal osteoporosis: the TRIO study

Influence of bone affinity on the skeletal distribution of fluorescently labeled bisphosphonates in vivo

(2012) Anke J Roelofs et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Benefits and Risks of Bisphosphonate Therapy for Osteoporosis

(2012) Sundeep Khosla et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Comparative Effectiveness of Drug Treatments to Prevent Fragility Fractures: A Systematic Review and Network Meta-Analysis

(2012) Mohammad Hassan Murad et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Bisphosphonates in the treatment of osteoporosis

(2012) K. E. Poole et al.   BMJ-British Medical Journal

Increases in Hip and Spine Bone Mineral Density are Predictive for Vertebral Antifracture Efficacy with Ibandronate

(2010) Paul D. Miller et al.   CALCIFIED TISSUE INTERNATIONAL

Performance of Quantitative Ultrasound Measurements of Bone for Monitoring Raloxifene Therapy

(2010) Margaret A. Paggiosi et al.   JOURNAL OF CLINICAL DENSITOMETRY

Long-Term Use of Bisphosphonates in Osteoporosis

(2010) Nelson B. Watts et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The Efficacy of Bisphosphonates in the Prevention of Vertebral, Hip, and Nonvertebral-Nonhip Fractures in Osteoporosis: A Network Meta-Analysis

(2010) Jeroen P. Jansen et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Effect of Once-Yearly Zoledronic Acid Five Milligrams on Fracture Risk and Change in Femoral Neck Bone Mineral Density

(2009) Richard Eastell et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Quantitative Ultrasound in the Management of Osteoporosis: The 2007 ISCD Official Positions

(2008) Marc-Antoine Krieg et al.   JOURNAL OF CLINICAL DENSITOMETRY

Quantitative Ultrasound at the Phalanges in Monitoring Alendronate Therapy

(2008) Nicolosi Mario Guido et al.   ULTRASOUND IN MEDICINE AND BIOLOGY